rescue vasoactive agents
in review
2 min read
Updated 2026-10-29
rescue vasoactive agents
Used after norepinephrine ± vasopressin ± epinephrine, or for a specific niche. Methylene blue: raises BP in refractory vasoplegia, survival benefit unproven (SSC: insufficient evidence). Angiotensin II and levosimendan have no Health Canada listing. Isoproterenol: chronotrope for bradycardia, torsades and the denervated heart. Midodrine: oral α1 agonist for weaning low-dose pressors (unproven) and HRS with octreotide.
agents
| agent | mechanism | dose | role | cautions |
|---|---|---|---|---|
| methylene blue | inhibits NO synthase and guanylate cyclase → restores vascular tone | 1–2 mg/kg IV over 5–30 min (trial regimens varied) | refractory septic shock, post-bypass vasoplegia; first-line for methaemoglobinaemia | serotonin toxicity with SSRIs/SNRIs (Health Canada warning); G6PD deficiency (haemolysis, less effective); falsely low SpO₂, blue-green urine |
| angiotensin II | AT1 agonist (RAAS pathway) | — (no Health Canada DPD listing, checked 2026-10-29) | catecholamine-refractory vasodilatory shock (ATHOS-3 (2017): better MAP response, no proven mortality gain) | thrombosis → VTE prophylaxis |
| levosimendan | calcium sensitiser + K-ATP opener | 0.1 mcg/kg/min (0.05–0.2), ESC (no Health Canada DPD listing) | low-output HF on β-blockers | hypotension; long-acting metabolite. Not for septic shock (SSC: suggest against) |
| isoproterenol | β1 + β2 agonist | 20–60 mcg IV bolus then 10–20 mcg, or 1–20 mcg/min titrated to HR | bradycardia when atropine fails (bridge to pacing), heart transplant | vasodilation → hypotension; ischaemia, tachyarrhythmia |
| midodrine | oral α1 agonist (prodrug) | HRS: 7.5–15 mg PO q8h with octreotide | HRS-AKI only if terlipressin is contraindicated and ICU norepinephrine isn’t possible (ADQI-ICA); weaning low-dose pressors | bradyarrhythmias. SSC: insufficient evidence in septic shock |
key points
- order in septic shock: norepinephrine → vasopressin → epinephrine; methylene blue as rescue. It may raise BP and probably shortens vasopressor duration by ~1 day (moderate certainty); the mortality effect is very uncertain, and 69% of the SSC panel “never or almost never” use it. Where vasopressin is unavailable it may be the only second-line option (SSC) → septic shock
- methylene blue + serotonergic drug (SSRI, SNRI, linezolid, fentanyl) → serotonin syndrome. Check the medication list first
- isoproterenol is a chronotrope and vasodilator, not a pressor; don’t use it for hypotension without bradycardia
- terlipressin (V1 agonist) for HRS-AKI → hepatorenal syndrome; hydroxocobalamin (cyanide, refractory vasoplegia) → toxicology
Standard pressors and inotropes: vasoactive drugs.
Prepared 2026-10-29. Not yet verified — check every number against the sources.